The Prevalence of Knee Symptoms, Radiographic, and Symptomatic Osteoarthritis at Four Time Points: The Johnston County Osteoarthritis Project, 1999-2018.


Journal

ACR open rheumatology
ISSN: 2578-5745
Titre abrégé: ACR Open Rheumatol
Pays: United States
ID NLM: 101740025

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 26 04 2021
accepted: 19 05 2021
pubmed: 11 7 2021
medline: 11 7 2021
entrez: 10 7 2021
Statut: ppublish

Résumé

To describe point prevalence of knee symptoms, radiographic knee osteoarthritis (rKOA), severe rKOA, and symptomatic rKOA at four time points in the longitudinal, population-based Johnston County Osteoarthritis Project (JoCo OA). Data were from 2573 JoCo OA participants with up to 18 years of follow-up (1999-2018) and standardized fixed-flexion knee radiographs read by a single, reliable expert musculoskeletal radiologist. The four outcomes were 1) self-reported knee symptoms, defined by "On most days, do you have pain, aching, or stiffness in your right/left knee?"; 2) rKOA, defined as a Kellgren-Lawrence grade (KLG) of 2 to 4); 3) severe rKOA, defined as a KLG of 3 or 4; and 4) symptomatic rKOA, defined as both symptoms and rKOA in the same joint. Weighted prevalence estimates and 95% confidence intervals (CIs) were generated overall and by age group, sex, race, and body mass index (BMI). Most recently (2017-2018, T4), the overall prevalence (percentage) of knee symptoms, rKOA, severe rKOA, and symptomatic rKOA was 41% (95% CI: 35-47%), 61% (95% CI: 56-67%), 35% (95% CI: 30-40%), and 30% (95% CI: 24-35%), respectively. From time point T1 to T4, prevalence increased for rKOA, severe rKOA, and symptomatic rKOA but not for knee symptoms. The prevalence of both severe rKOA (17-39%) and symptomatic rKOA (23-30%) was consistently higher among women. The prevalence of all outcomes was higher among those with higher BMI and among Black participants at all time points, particularly rKOA (35-69%) and severe rKOA (22-46%). These updated estimates demonstrate a large and increasing burden of knee OA, particularly among women and Black individuals.

Identifiants

pubmed: 34245232
doi: 10.1002/acr2.11295
pmc: PMC8363850
doi:

Types de publication

Journal Article

Langues

eng

Pagination

558-565

Subventions

Organisme : NCCDPHP CDC HHS
ID : U01DP003206
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP006266
Pays : United States
Organisme : NIAMS NIH HHS
ID : P60 AR030701
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30AR072580
Pays : United States
Organisme : NIAMS NIH HHS
ID : P60AR049465
Pays : United States
Organisme : Association of Schools of Public Health/CDC
ID : S043
Organisme : ACL HHS
ID : U01DP006266
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01DP006266
Pays : United States
Organisme : NIAMS NIH HHS
ID : P60AR064166
Pays : United States
Organisme : NIAMS NIH HHS
ID : P60AR30701
Pays : United States
Organisme : Association of Schools of Public Health/CDC
ID : S3486
Organisme : Association of Schools of Public Health/CDC
ID : S1734

Informations de copyright

© 2021 The Authors. ACR Open Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology.

Références

J Rheumatol. 2007 Jan;34(1):172-80
pubmed: 17216685
Arthritis Care Res. 1995 Dec;8(4):242-50
pubmed: 8605262
Arthritis Rheum. 2012 Jul;64(7):2243-51
pubmed: 22422507
Arthritis Rheum. 2008 Sep 15;59(9):1207-13
pubmed: 18759314
Osteoarthritis Cartilage. 2011 Nov;19(11):1270-85
pubmed: 21907813
Ann Rheum Dis. 1957 Dec;16(4):494-502
pubmed: 13498604
Clin Interv Aging. 2018 Nov 14;13:2339-2349
pubmed: 30532524
Osteoarthritis Cartilage. 2019 Apr;27(4):593-602
pubmed: 30583096
Acta Orthop. 2018 Apr;89(2):177-183
pubmed: 29160139
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
Ann Intern Med. 2011 Dec 6;155(11):725-32
pubmed: 22147711
J Rheumatol. 2006 Nov;33(11):2271-9
pubmed: 17013996
J Rheumatol. 2013 Aug;40(8):1241-3
pubmed: 23908527
Arthritis Care Res (Hoboken). 2016 Dec;68(12):1743-1750
pubmed: 27014966
Arthritis Rheum. 1987 Aug;30(8):914-8
pubmed: 3632732

Auteurs

Amanda E Nelson (AE)

University of North Carolina at Chapel Hill.

David Hu (D)

University of North Carolina at Chapel Hill.

Liubov Arbeeva (L)

University of North Carolina at Chapel Hill.

Carolina Alvarez (C)

University of North Carolina at Chapel Hill.

Rebecca J Cleveland (RJ)

University of North Carolina at Chapel Hill.

Todd A Schwartz (TA)

University of North Carolina at Chapel Hill.

Louise B Murphy (LB)

Centers for Disease Control and Prevention, Atlanta, Georgia, United States.
Optum Life Sciences, Eden Prairie, Minnesota, United States.

Charles G Helmick (CG)

Centers for Disease Control and Prevention, Atlanta, Georgia, United States.

Leigh F Callahan (LF)

University of North Carolina at Chapel Hill.

Jordan B Renner (JB)

University of North Carolina at Chapel Hill.

Joanne M Jordan (JM)

University of North Carolina at Chapel Hill.

Yvonne M Golightly (YM)

University of North Carolina at Chapel Hill.

Classifications MeSH